Article
Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
Expert review of anti-infective therapy - 1 Feb 2014
Liu Qinfang, Ma Jingjiao, Strayer David R, Mitchell William M, Carter William A, Ma Wenjun, Richt Juergen A
Abstract excerpt
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths (as of September, 2013) in China. Because of the lack of existing immunity against H7 subtype influenza viruses in the human population and the absence of a licensed commercial vaccine, antiviral drugs are critical tools for the treatment of infection with this novel H7N9. Both M2-ion channel blockers and neuraminidase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.